Tumor‐associated macrophages impair NK cell IFN‐γ production and contribute to tumor progression in clear cell renal cell carcinoma

Sol Yanel Núñez,Aldana Trotta,María Victoria Regge,María Sofía Amarilla,Florencia Secchiari,Jessica Mariel Sierra,María Cecilia Santilli,Mariana Gantov,Agustín Rovegno,Nicolás Richards,Carlos Ameri,Hernando Ríos Pita,Luis Rico,Mauro Mieggi,Gonzalo Vitagliano,Leandro Blas,Adrián David Friedrich,Carolina Inés Domaica,Mercedes Beatriz Fuertes,Norberto Walter Zwirner
DOI: https://doi.org/10.1002/eji.202350878
2024-04-08
European Journal of Immunology
Abstract:Tumor‐associated macrophages (TAM) promote tumor growth in clear cell renal cell carcinoma (ccRCC) and inhibit IFN‐γ production by NK cells. TAM depletion generates reinvigorated tumor‐infiltrating NK cells with higher IFN‐γ production, expression of T‐bet and NKG2D, and reduced expression of PD‐1 and TIM‐3, resulting in delayed tumor growth. Tumor‐associated macrophages (TAM) are abundant in several tumor types and usually correlate with poor prognosis. Previously, we demonstrated that anti‐inflammatory macrophages (M2) inhibit NK cell effector functions. Here, we explored the impact of TAM on NK cells in the context of clear‐cell renal cell carcinoma (ccRCC). Bioinformatics analysis revealed that an exhausted NK cell signature strongly correlated with an M2 signature. Analysis of TAM from human ccRCC samples confirmed that they exhibited an M2‐skewed phenotype and inhibited IFN‐γ production by NK cells. Moreover, human M0 macrophages cultured with conditioned media from ccRCC cell lines generated macrophages with an M2‐skewed phenotype (TAM‐like), which alike TAM, displayed suppressive activity on NK cells. Moreover, TAM depletion in the mouse Renca ccRCC model resulted in delayed tumor growth and reduced volume, accompanied by an increased frequency of IFN‐γ‐producing tumor‐infiltrating NK cells that displayed heightened expression of T‐bet and NKG2D and reduced expression of the exhaustion‐associated co‐inhibitory molecules PD‐1 and TIM‐3. Therefore, in ccRCC, the tumor microenvironment polarizes TAM toward an immunosuppressive profile that promotes tumor‐infiltrating NK cell dysfunction, contributing to tumor progression. In addition, immunotherapy strategies targeting TAM may result in NK cell reinvigoration, thereby counteracting tumor progression.
immunology
What problem does this paper attempt to address?